{"id":"https://openalex.org/W42008395","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","title":"Phase I study of tipifarnib and sorafenib in patients with biopsiable advanced cancers (NCI protocol 7156 supported by NCI grant UO1 CA062461)","display_name":"Phase I study of tipifarnib and sorafenib in patients with biopsiable advanced cancers (NCI protocol 7156 supported by NCI grant UO1 CA062461)","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W42008395","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","mag":"42008395"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.3549","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026095888","display_name":"David S. Hong","orcid":"https://orcid.org/0000-0001-8721-1609","observed_orcids":["https://orcid.org/0000-0001-8721-1609"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. S. Hong","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022436659","display_name":"Luis H. Camacho","orcid":"https://orcid.org/0000-0003-1856-8641","observed_orcids":["https://orcid.org/0000-0003-1856-8641"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Camacho","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053460346","display_name":"Chaan S. Ng","orcid":"https://orcid.org/0000-0001-9261-7021","observed_orcids":["https://orcid.org/0000-0001-9261-7021"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Ng","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101583433","display_name":"James R. Wright","orcid":"https://orcid.org/0000-0002-8601-925X","observed_orcids":["https://orcid.org/0000-0002-8601-925X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wright","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083929738","display_name":"Robert Alan Newman","orcid":"https://orcid.org/0000-0001-5661-5846","observed_orcids":["https://orcid.org/0000-0001-5661-5846"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. A. Newman","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065640278","display_name":"SL Moulder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Moulder","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Tannir","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036211173","display_name":"Jennifer J. Wheler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wheler","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015826850","display_name":"Rabia Sannam Khan","orcid":"https://orcid.org/0000-0002-8327-866X","observed_orcids":["https://orcid.org/0000-0002-8327-866X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Khan","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Kurzrock","raw_affiliation_strings":["Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Texas MD Anderson Cancer Ctr, Houston, TX; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"3549","last_page":"3549"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.37209999561309814,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tipifarnib","display_name":"tipifarnib","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.550000011920929},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.6489999890327454},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibition","display_name":"farnesyltransferase inhibition","score":0.8569999933242798},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8659999966621399},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8429999947547913},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9319999814033508},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7089999914169312},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8870000243186951},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.7409999966621399},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6060000061988831},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5249999761581421},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.5680000185966492},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.8420000076293945},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.5799999833106995},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5509999990463257},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5820000171661377},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9273446798324585},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8945910930633545},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7800382375717163},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5398032665252686},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.5209011435508728},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4903147518634796},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.452827513217926},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4149523377418518},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4136788547039032},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3953106105327606},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.20139756798744202},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.3549","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3549","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W910853","https://openalex.org/W2138396354","https://openalex.org/W1816852","https://openalex.org/W2590188240","https://openalex.org/W2889163080","https://openalex.org/W2119575895","https://openalex.org/W2225644272","https://openalex.org/W2148171430","https://openalex.org/W2601313435","https://openalex.org/W2151507583"],"abstract_inverted_index":{"3549":[0],"Background:":[1],"The":[2,76,230,314],"Ras":[3,59],"and":[4,15,49,72,101,155,178,207,241,342],"Raf":[5],"kinases":[6],"are":[7,108,251],"sequential":[8],"signaling":[9],"proteins":[10],"in":[11,25,61,110],"the":[12,68,111,153,168,248,298],"MAPK":[13],"pathway":[14],"inhibition":[16],"of":[17,29,53,83,96,99,104,119,152,203,247,300],"both":[18],"targets":[19],"may":[20],"confer":[21],"synergistic":[22],"effects,":[23],"particularly":[24],"tumors":[26],"with":[27,87,297],"activation":[28],"either":[30],"kinase":[31],"through":[32],"mutation":[33],"or":[34],"other":[35],"mechanisms.":[36],"Therefore,":[37],"we":[38],"sought":[39],"to":[40,66,217,284,318,335],"combine":[41],"sorafenib,":[42],"a":[43,62,79,88,117,201],"multikinase":[44],"inhibitor":[45,52],"(Raf,":[46],"VEGFR,":[47],"PDGFR)":[48],"tipifarnib":[50,219,320,341],"an":[51,265],"farnesyltransferase":[54],"that":[55],"is":[56],"critical":[57],"for":[58,262,270,276],"activity":[60],"phase":[63,80],"I":[64,81],"study":[65],"determine":[67],"safety,":[69],"pharmacokinetics":[70],"(PK),":[71],"tumor":[73],"response.":[74],"Methods:":[75],"trial":[77,82],"was":[78,187,316],"advanced":[84],"cancer":[85],"patients(pts)":[86],"conventional":[89],"dose":[90,194],"escalation":[91,186],"design.":[92],"Each":[93],"cycle":[94],"consisted":[95],"28":[97],"days":[98,103],"sorafenib":[100,179,223,325],"21":[102],"tipifarnib.":[105],"Dose":[106,185],"levels":[107,311],"listed":[109],"table":[112,191],".":[113],"Results:":[114],"To":[115],"date,":[116],"total":[118],"27":[120,249],"pts":[121,161,198,250,254,261],"have":[122],"been":[123,215],"enrolled":[124],"(median":[125],"age":[126],"54.5":[127],"yrs,":[128],"M:F":[129],"1:1.":[130],"3":[131,133,139,164,205,209],"RCC,":[132],"breast,":[134],"4":[135,137,141],"sarcoma,":[136],"melanoma,":[138],"CRC,":[140],"thyroid,":[142],"2":[143,259],"H&N,":[144],"one":[145,147,150,156,273],"thymic,":[146],"adrenal":[148,266],"cortical,":[149],"SCC":[151],"lung,":[154],"unknown":[157],"primary":[158],"SCC).":[159],"Two":[160],"developed":[162],"grade":[163,204,208],"DLT-skin":[165],"rash":[166,206,243],"on":[167],"first":[169],"dosing":[170],"level":[171,195],"(tipifarnib":[172],"at":[173,180,321,326],"100":[174,220,322],"mg":[175,182,221,225,228,323,328,331],"po":[176,183],"BID":[177],"400":[181,224,327],"BID).":[184],"modified":[188],"as":[189],"per":[190],"below.":[192],"At":[193],"4,":[196],"2/5":[197],"entered":[199],"experienced":[200],"DLT":[202],"drug":[210],"fever,":[211],"therefore":[212],"MTD":[213,315],"has":[214],"determined":[216,317],"be":[218,319],"BID,":[222,324],"qam,":[226,329],"200":[227,330],"qpm.":[229,332],"most":[231],"common":[232],"treatment":[233],"related":[234],"toxicities":[235],"included":[236],"lymphopenia":[237],"(18),":[238],"hyperglycemia":[239],"(17),":[240],"skin":[242],"(14).":[244],"Currently,":[245],"19":[246],"evaluable;":[252],"13":[253],"had":[255],"SD":[256],"(8\u201344":[257],"weeks);":[258],"RCC":[260],"32":[263,271],"weeks,":[264,272],"cortical":[267],"ca":[268],"pt":[269,275],"melanoma":[274],"44":[277],"weeks.":[278],"PK":[279,287,290,333],"analysis":[280],"suggested":[281],"findings":[282],"similar":[283],"single":[285,308],"agent":[286,309],"profiles,":[288],"no":[289],"interactions":[291],"were":[292,312],"apparent.":[293],"Conclusions:":[294],"Significant":[295],"toxicity":[296],"combination":[299],"these":[301],"two":[302],"agents,":[303],"even":[304],"doses":[305],"well":[306],"below":[307],"maximum":[310],"observed.":[313],"analysis,":[334],"date":[336],"show,no":[337],"pharmacokinetic":[338],"interaction":[339],"between":[340],"sorafenib.":[343],"[Table:":[344,347],"see":[345,348],"text]":[346,349]},"counts_by_year":[{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}